Download PDF
Thromb Haemost 2011; 105(06): 1103-1105
DOI: 10.1160/TH10-09-0608
Letters to the Editor
Schattauer GmbH

Warfarin treatment outcomes in children monitored at home with a point-of-care device

Tina T. Biss
1   Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
,
Peter J. Avery
2   School of Mathematics and Statistics, Newcastle University, Newcastle upon Tyne, UK
,
Patricia M. Walsh
3   Department of Paediatric Cardiology, The Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK
,
Farhad Kamali
1   Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
› Author Affiliations Financial support: Dr. Tina Biss is supported by a clinical fellowship grant from Baxter Healthcare & the Royal College of Pathologists, UK.
Further Information

Publication History

Received: 24 September 2010

Accepted after major revision: 14 February 2011

Publication Date:
28 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Streif W, Andrew M, Marzinotto V. et al. Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. Blood 1999; 94: 3007-3014.
    PubMedGoogle Scholar
  • 2 Black KL, Bauman ME, Kuhle S. et al. Warfarin therapy induced coagulopathy in children: assessment of a conservative approach. J Thromb Haemost. 2009 7 (Suppl1): OC-TU-066 (Abstract).
    PubMedGoogle Scholar
  • 3 Massicotte P, Julian JA, Gent M. et al. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thromb Res 2003; 109: 85-92.
    CrossrefPubMedGoogle Scholar
  • 4 Newall F, Campbell J, Savoia H. et al. Incidence of major bleeding in a large paediatric cohort of patients requiring warfarin therapy. J Thromb Haemost. 2005 3 (Suppl1): OR357 (Abstract).
    PubMedGoogle Scholar
  • 5 Newall F, Savoia H, Campbell J. et al. Anticoagulation clinics for children achieve improved warfarin management. Thromb Res 2004; 114: 5-9.
    CrossrefPubMedGoogle Scholar
  • 6 Bradbury MJ, Taylor G, Short P. et al. A comparative study of anticoagulant control in patients on long-term warfarin using home and hospital monitoring of the international normalised ratio. Arch Dis Child 2008; 93: 303-306.
    CrossrefPubMedGoogle Scholar
  • 7 Newall F, Monagle P, Johnston L. Home INR monitoring of oral anticoagulant therapy in children using the CoaguchekTM S point-of-care monitor and a robust education program. Thromb Res 2006; 118: 587-593.
    CrossrefPubMedGoogle Scholar
  • 8 Bhat D, Upponi A, Rakecha A. et al. Evaluating safety, effectiveness, and user satisfaction of home international normalized ratio monitoring service: Experience from a tertiary pediatric cardiology unit in the United Kingdom. Pediatr Cardiol 2010; 31: 18-21.
    CrossrefPubMedGoogle Scholar
  • 9 Bauman ME, Black KL, Massicotte MP. et al. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin. Thromb Haemost 2008; 99: 1097-1103.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Marzinotto V, Monagle P, Chan A. et al. Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting. Pediatr Cardiol 2000; 21: 347-352.
    CrossrefPubMedGoogle Scholar
  • 11 Greenway A, Ignjatovic V, Summerhayes R. et al. Point-of-care monitoring of oral anticoagulant therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95). Thromb Haemost 2009; 102: 159-165.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Bauman ME, Black K, Kuhle S. KIDCLOT©: The importance of validated educational intervention for optimal long term warfarin management in children. Thromb Res 2009; 123: 707-709.
    CrossrefPubMedGoogle Scholar